PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease

Movement Disorders

Volumn 26, Issue 7, 2011, Pages 1259-1265

  Stocchi, Fabrizio ^a   Giorgi, Luigi ^b   Hunter, Brian ^b   Schapira, Anthony Hv ^c  

^a IRCCS SAN RAFFAELE PISANA   (Italy)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Motor fluctuations; Once daily treatment; Parkinson's disease; Ropinirole

Indexed keywords

LEVODOPA; ROPINIROLE;

ABDOMINAL PAIN; ADULT; ARTICLE; CONSTIPATION; DISEASE CONTROL; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG FORMULATION; DRUG RELEASE; DRUG TOLERABILITY; DYSKINESIA; DYSPEPSIA; FATIGUE; FEMALE; HALLUCINATION; HEADACHE; HUMAN; HYPOTENSION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; VOMITING;

AGED; ANTIPARKINSON AGENTS; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INDOLES; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 79959364697     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23498     Document Type: Article

References (10)

1. Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006; 5: 235-245.
2. Schapira AH, Bezard E, Brotchie J, et al. Novel pharmacological targets for the treatment of Parkinson's disease. Nat Rev Drug Discov 2006; 5: 845-854.
3. Grosset KA, Bone I, Grosset DG. Suboptimal medication adherence in Parkinson's disease. Mov Disord 2005; 20: 1502-1507.
4. Schapira AH. Excessive daytime sleepiness in Parkinson's disease. Neurology 2004; 63: S24-S27.
5. Olanow CW, Obeso JA, Stocchi F. Drug insight: continuous dopaminergic stimulation in the treatment of Parkinson's disease. Nat Clin Pract Neurol 2006; 2: 382-392.
6. Tompson D, Vearer D. Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease. Clin Ther 2007; 29: 2654-2666.
7. Stocchi F, Hersh BP, Scott BL, Nausieda PA, Giorgi L; EASE-PD Monotherapy Study Investigators. Ropinirole 24-hour prolonged release and ropinirole immediate release in early Parkinson's disease: a randomized, double-blind, noninferiority crossover study. Curr Med Res Opin 2008; 24: 2883-2895.
8. Lieberman A, Olanow CW, Sethi K, et al. A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease. Ropinirole Study Group. Neurology 1998; 51: 1057-1062.
9. Pahwa R, Stacy MA, Factor SA, et al. Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease. Neurology 2007; 68: 1108-1115.
10. Schapira AH. Treatment options in the modern management of Parkinson disease. Arch Neurol 2007; 64: 1083-1088.